Piper Sandler maintains overweight on Inspire Medical stock
Piper Sandler reaffirmed its positive stance on Inspire Medical Systems (NYSE:NYSE:INSP), maintaining an Overweight rating with a $260.00 price target. The endorsement comes after a steep 14.15% ...
Inspire Medical Systems (INSP) Receives a Buy from Lake Street
Lake Street analyst Frank Takkinen reiterated a Buy rating on Inspire Medical Systems (INSP – Research Report) today and set a price target of ...
Future Market Insights2d
Sleep Apnea Implants Industry to Reach USD 1,158.1 Million by 2033 at a 13.8% of CAGR
The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...
BioPharma Dive2d
Ozempic, Ibrance among next drugs picked by Medicare for price talks
Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...
Piper Sandler Keeps Their Buy Rating on Inspire Medical Systems (INSP)
Piper Sandler analyst Adam Maeder maintained a Buy rating on Inspire Medical Systems (INSP – Research Report) today and set a price target of ...